Literature DB >> 2542615

Transcription of the human beta interferon gene is inhibited by hepatitis B virus.

J S Twu1, R H Schloemer.   

Abstract

The manner by which the trans-acting factor encoded by the 1,828-base-pair (bp) BamHI DNA fragment of hepatitis B virus (HBV) suppresses the production of human beta interferon was determined. Steady-state levels of RNA specific for human beta interferon were decreased in cells that contained the 1,828-bp BamHI DNA fragment of HBV. The reduced accumulation of interferon-specific RNA was due to an inhibition of transcription of the interferon gene by the HBV trans-acting moiety. The expression of the interferon gene that is under the control of a heterologous promoter such as the simian virus 40 early promoter was not altered by the presence of the 1,828-bp BamHI HBV DNA fragment. In contrast, the HBV moiety inhibited the expression of the cat gene, whose expression is controlled by the regulatory DNA region of the human beta interferon gene. These results indicate that the HBV trans-acting moiety suppresses the expression of the human beta interferon gene at the transcriptional level by interacting with the regulatory DNA sequences 5' to the coding sequences for beta interferon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542615      PMCID: PMC250862     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Transcriptional trans-activating function of hepatitis B virus.

Authors:  J S Twu; R H Schloemer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  trans-activation of viral enhancers by the hepatitis B virus X protein.

Authors:  D F Spandau; C H Lee
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

Review 3.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles.

Authors:  M R Bavand; O Laub
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Overlapping positive and negative regulatory domains of the human beta-interferon gene.

Authors:  S Goodbourn; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Non-production of interfering substances by serum from patients with infectious hepatitis.

Authors:  P E Taylor; A J Zuckerman
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472

7.  Absence of circulating interferon in patients with infectious and serum hepatitis.

Authors:  E F Wheelock; S Schenker; B Combes
Journal:  Proc Soc Exp Biol Med       Date:  1968-05

8.  Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis.

Authors:  D A Hill; J H Walsh; R H Purcell
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

9.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication.

Authors:  C Chang; G Enders; R Sprengel; N Peters; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner.

Authors:  T K Antonucci; W J Rutter
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

View more
  8 in total

Review 1.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice.

Authors:  S Perfumo; L Amicone; S Colloca; M Giorgio; L Pozzi; M Tripodi
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 3.  Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response.

Authors:  G R Foster; H C Thomas
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

4.  Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.

Authors:  Z Rahmani; K W Huh; R Lasher; A Siddiqui
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.

Authors:  E Gordien; O Rosmorduc; C Peltekian; F Garreau; C Bréchot; D Kremsdorf
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners.

Authors:  Sujeong Kim; Hye-Young Kim; Seungmin Lee; Sung Woo Kim; Seonghyang Sohn; Kyongmin Kim; Hyeseong Cho
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

7.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene.

Authors:  T M Whitten; A T Quets; R H Schloemer
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.